These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
702 related articles for article (PubMed ID: 23268613)
1. Locally derived versus guideline-based approach to treatment of hospital-acquired pneumonia in the trauma intensive care unit. Becher RD; Hoth JJ; Rebo JJ; Kendall JL; Miller PR Surg Infect (Larchmt); 2012 Dec; 13(6):352-9. PubMed ID: 23268613 [TBL] [Abstract][Full Text] [Related]
2. Multidrug-resistant pathogens and pneumonia: comparing the trauma and surgical intensive care units. Becher RD; Hoth JJ; Neff LP; Rebo JJ; Martin RS; Miller PR Surg Infect (Larchmt); 2011 Aug; 12(4):267-72. PubMed ID: 21524206 [TBL] [Abstract][Full Text] [Related]
3. Using local microbiologic data to develop institution-specific guidelines for the treatment of hospital-acquired pneumonia. Beardsley JR; Williamson JC; Johnson JW; Ohl CA; Karchmer TB; Bowton DL Chest; 2006 Sep; 130(3):787-93. PubMed ID: 16963676 [TBL] [Abstract][Full Text] [Related]
4. Empiric antibiotics pending bronchoalveolar lavage data in patients without pneumonia significantly alters the flora, but not the resistance profile, if a subsequent pneumonia develops. Thakkar RK; Monaghan SF; Adams CA; Stephen A; Connolly MD; Gregg S; Cioffi WG; Heffernan DS J Surg Res; 2013 May; 181(2):323-8. PubMed ID: 22906560 [TBL] [Abstract][Full Text] [Related]
5. [Guidelines for treatment of pneumonia in intensive care units]. Emmi V Infez Med; 2005; Suppl():7-17. PubMed ID: 16801748 [TBL] [Abstract][Full Text] [Related]
6. Utility of ampicillin-sulbactam for empiric treatment of ventilator-associated pneumonia in a trauma population. McMillian WD; Bednarik JL; Aloi JJ; Ahern JW; Crookes BA J Trauma; 2010 Oct; 69(4):861-5. PubMed ID: 20938272 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of a clinical pathway for ventilator-associated pneumonia: changes in bacterial flora and the adequacy of empiric antibiotics over a three-year period. Wood GC; Mueller EW; Croce MA; Boucher BA; Hanes SD; Fabian TC Surg Infect (Larchmt); 2005; 6(2):203-13. PubMed ID: 16128627 [TBL] [Abstract][Full Text] [Related]
8. Hospital-acquired pneumonia and ventilator-associated pneumonia in adults at Siriraj Hospital: etiology, clinical outcomes, and impact of antimicrobial resistance. Werarak P; Kiratisin P; Thamlikitkul V J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S126-38. PubMed ID: 20364567 [TBL] [Abstract][Full Text] [Related]
9. MICROBIAL PROFILE AND ANTIBIOTIC SUSCEPTIBILITY PATTERNS OF PATHOGENS CAUSING VENTILATOR- ASSOCIATED PNEUMONIA AT INTENSIVE CARE UNIT, SESTRE MILOSRDNICE UNIVERSITY HOSPITAL CENTER, ZAGREB, CROATIA. Turković TM; Grginić AG; Cucujić BĐ; Gašpar B; Širanović M; Perić M Acta Clin Croat; 2015 Jun; 54(2):127-35. PubMed ID: 26415308 [TBL] [Abstract][Full Text] [Related]
10. Probability of pharmacodynamic target attainment with standard and prolonged-infusion antibiotic regimens for empiric therapy in adults with hospital-acquired pneumonia. Kim A; Kuti JL; Nicolau DP Clin Ther; 2009 Nov; 31(11):2765-78. PubMed ID: 20110018 [TBL] [Abstract][Full Text] [Related]
11. Defining Pathogen and Susceptibility Patterns for Early Versus Late Ventilator Associated Pneumonia in Trauma Patients to Guide Empiric Treatment Decisions. Alexander KM; Davis SN; Butts CC; Morgan J; Croft LK; Lee YL; Kinnard CM; Polite NM; Mbaka MI; Williams AY; Barrington RA; Audia JP; Simmons JD Am Surg; 2023 Nov; 89(11):4536-4541. PubMed ID: 35979859 [TBL] [Abstract][Full Text] [Related]
12. Incidence of nephrotoxicity and association with vancomycin use in intensive care unit patients with pneumonia: retrospective analysis of the IMPACT-HAP Database. Cano EL; Haque NZ; Welch VL; Cely CM; Peyrani P; Scerpella EG; Ford KD; Zervos MJ; Ramirez JA; Kett DH; Clin Ther; 2012 Jan; 34(1):149-57. PubMed ID: 22284995 [TBL] [Abstract][Full Text] [Related]
13. A new strategy for healthcare-associated pneumonia: a 2-year prospective multicenter cohort study using risk factors for multidrug-resistant pathogens to select initial empiric therapy. Maruyama T; Fujisawa T; Okuno M; Toyoshima H; Tsutsui K; Maeda H; Yuda H; Yoshida M; Kobayashi H; Taguchi O; Gabazza EC; Takei Y; Miyashita N; Ihara T; Brito V; Niederman MS Clin Infect Dis; 2013 Nov; 57(10):1373-83. PubMed ID: 23999080 [TBL] [Abstract][Full Text] [Related]
14. A practical application of practice-based learning: development of an algorithm for empiric antibiotic coverage in ventilator-associated pneumonia. Miller PR; Partrick MS; Hoth JJ; Meredith JW; Chang MC J Trauma; 2006 Apr; 60(4):725-9; discussion 729-31. PubMed ID: 16612290 [TBL] [Abstract][Full Text] [Related]
16. Intermediate risk of multidrug-resistant organisms in patients who admitted intensive care unit with healthcare-associated pneumonia. Lee H; Park JY; Lee T; Lee YJ; Lim HJ; Park JS; Yoon HI; Lee JH; Lee CT; Cho YJ Korean J Intern Med; 2016 May; 31(3):525-34. PubMed ID: 26968189 [TBL] [Abstract][Full Text] [Related]
17. Validation of the American Thoracic Society-Infectious Diseases Society of America guidelines for hospital-acquired pneumonia in the intensive care unit. Ferrer M; Liapikou A; Valencia M; Esperatti M; Theessen A; Antonio Martinez J; Mensa J; Torres A Clin Infect Dis; 2010 Apr; 50(7):945-52. PubMed ID: 20175690 [TBL] [Abstract][Full Text] [Related]
18. Distribution and antibiotic susceptibility of pathogens isolated from adults with hospital-acquired and ventilator-associated pneumonia in intensive care unit. Djordjevic ZM; Folic MM; Jankovic SM J Infect Public Health; 2017; 10(6):740-744. PubMed ID: 28189513 [TBL] [Abstract][Full Text] [Related]
19. Implementation of guidelines for management of possible multidrug-resistant pneumonia in intensive care: an observational, multicentre cohort study. Kett DH; Cano E; Quartin AA; Mangino JE; Zervos MJ; Peyrani P; Cely CM; Ford KD; Scerpella EG; Ramirez JA; Lancet Infect Dis; 2011 Mar; 11(3):181-9. PubMed ID: 21256086 [TBL] [Abstract][Full Text] [Related]